The American Society of Tropical Medicine and Hygiene (ASTMH) assisted with publication expenses.
Cambau E, Perani E, Guillemin I, Jamet P, Ji B, 1997. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae. Lancet 349: 103–104.
Cambau E 2018. Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15. Clin Microbiol Infect 24: 1305–1310.
Maeda S, Matsuoka M, Nakata N, Kai M, Maeda Y, Hashimoto K, Kimura H, Kobayashi K & Kashiwabara Y 2001. Multidrug resistant Mycobacterium leprae from patients with leprosy. Antimicrob Agents Chemother 45: 3635–3639.
Lavania M 2018. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients. J Glob Antimicrob Resist 12: 214–219.
Araujo S 2017. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients. PLoS Negl Trop Dis 11: e0005506.
Rosa PS 2019. Emergence and transmission of drug-/multidrug-resistant Mycobacterium leprae in a former leprosy colony in the Brazilian amazon. Clin Infect Dis: ciz570.
Sinha S, Sardana K, Agrawal D, Malhotra P, Lavania M, Ahuja M, 2019. Multidrug resistance as a cause of steroid-nonresponsive downgrading type I reaction in Hansen’s disease. Int J Mycobacteriol 8: 305–308.
Arora P, Sardana K, Agarwal A, Lavania M, 2019. Resistance as a cause for chronic steroid dependent ENL - a novel paradigm with potential implications in management. Lepr Rev 90: 201–205.